| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.00B | 11.82B | 11.09B | 10.80B | 10.54B | 9.97B |
| Gross Profit | 6.17B | 6.08B | 5.71B | 5.45B | 5.23B | 4.68B |
| EBITDA | 4.12B | 4.08B | 3.83B | 3.62B | 3.53B | 3.06B |
| Net Income | 2.35B | 2.19B | 1.86B | 1.76B | 1.73B | 1.46B |
Balance Sheet | ||||||
| Total Assets | 16.69B | 17.08B | 16.71B | 14.74B | 14.36B | 13.12B |
| Cash, Cash Equivalents and Short-Term Investments | 4.02B | 4.53B | 6.95B | 6.27B | 5.17B | 6.22B |
| Total Debt | 985.00M | 1.81B | 1.81B | 1.95B | 2.40B | 2.30B |
| Total Liabilities | 3.70B | 4.21B | 4.48B | 4.16B | 4.62B | 4.32B |
| Stockholders Equity | 12.99B | 12.87B | 12.23B | 10.58B | 9.74B | 8.79B |
Cash Flow | ||||||
| Free Cash Flow | 663.00M | 2.70B | 2.85B | 2.56B | 2.84B | 1.95B |
| Operating Cash Flow | 686.00M | 2.84B | 2.98B | 2.61B | 2.90B | 2.33B |
| Investing Cash Flow | -823.00M | -2.45B | -553.00M | 222.00M | -2.26B | -377.00M |
| Financing Cash Flow | -648.00M | -2.82B | -1.75B | -1.74B | -1.69B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥122.95B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
74 Outperform | ¥37.74B | 13.44 | ― | 2.60% | 5.57% | 27.50% | |
72 Outperform | ¥1.03T | 10.73 | ― | 3.37% | 5.24% | 69.92% | |
68 Neutral | ¥32.11B | 8.57 | ― | 4.66% | -13.01% | 9.74% | |
64 Neutral | ¥392.93B | 11.14 | ― | 3.62% | -0.03% | -42.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥43.28B | 6.79 | ― | 3.90% | 0.17% | 58.30% |